T.A. Sciences, Inc. For Profit
Aegle Therapeutics is a clinical stage regenerative medicine company that develops novel therapeutics.
Last Funding Type:
Series D
Headquarters:
United States
Investors Number:
8
Technology:
Other
Industry:
Regenerative medicine
Estimated Revenue:
Less than $1M
Total Funding:
$82.7M